Abstract
In the course of a microbial product screening aimed at the discovery of novel antibiotics acting on bacterial protein synthesis, a complex of three structurally related tetrapeptides, namely, GE81112 factors A, B, and B1, was isolated from a Streptomyces sp. The screening was based on a cell-free assay of bacterial protein synthesis driven by a model mRNA containing natural initiation signals. In this study we report the production, isolation, and structure determination of these novel, potent and selective inhibitors of cell-free bacterial protein synthesis, which stably bind the 30S ribosomal subunit and inhibit the formation of fMet-puromycin. They did not inhibit translation by yeast ribosomes in vitro. Spectroscopic analyses revealed that they are tetrapeptides constituted by uncommon amino acids. While GE81112 factors A, B, and B1 were effective in inhibiting bacterial protein synthesis in vitro, they were less active against Gram-positive and Gram-negative bacterial cells. Cells grown in minimal medium were more susceptible to the compounds than those grown in rich medium, and this is most likely due to competition or regulation by medium components during peptide uptake. The novelty of the chemical structure and of the...Continue Reading
References
Jun 1, 1977·Journal of Bacteriology·M C LucasN H Giles
May 15, 1992·The Biochemical Journal·P LandiniM Denaro
Oct 1, 1980·The Biochemical Journal·J Hughes, G Mellows
Jul 9, 1993·Journal of Chromatography·M PawlowskaD W Armstrong
Dec 31, 2003·Journal of Molecular Biology·Letizia BrandiJ Stephen Lodmell
Citations
Jun 17, 2010·The Journal of Antibiotics·Stefano DonadioDaniela Jabes
Nov 23, 2007·Natural Product Reports·Dwight D BakerVineet Rajgarhia
Aug 17, 2010·The Journal of Biological Chemistry·Tina M BinzRolf Müller
Sep 4, 2012·Nucleic Acids Research·Attilio FabbrettiClaudio O Gualerzi
May 16, 2006·RNA·Letizia BrandiClaudio O Gualerzi
Sep 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Pohl MilonClaudio O Gualerzi
Aug 15, 2014·The Journal of Antibiotics·Enrico Selva
Apr 16, 2008·Expert Opinion on Therapeutic Targets·Letizia BrandiClaudio O Gualerzi
Jun 1, 2007·Expert Opinion on Drug Discovery·Stefano DonadioClaudio O Gualerzi
Apr 26, 2011·FEBS Letters·Attilio FabbrettiLetizia Brandi
Jul 7, 2009·Journal of Molecular Biology·Beatriz Llano-SoteloAlexander S Mankin
Apr 14, 2016·Proceedings of the National Academy of Sciences of the United States of America·Attilio FabbrettiPaola Fucini
Nov 26, 2009·Critical Reviews in Biochemistry and Molecular Biology·Daniel N Wilson
May 28, 2016·Antibiotics·Alessandro MaioClaudio O Gualerzi
Jul 14, 2018·Angewandte Chemie·Gerrit JürjensArmin Bauer
Jan 24, 2016·Applied and Environmental Microbiology·Makoto HibiJun Ogawa
Jun 6, 2018·Frontiers in Molecular Biosciences·Yury S PolikanovDaniel N Wilson
Oct 15, 2019·Angewandte Chemie·Christian R ZwickHans Renata
Jan 15, 2015·Journal of Biomolecular Screening·Matteo RaneriFederica Briani
Feb 6, 2021·Accounts of Chemical Research·Carter N Stout, Hans Renata
Jul 31, 2013·ACS Chemical Biology·Sonia I MaffioliClaudio O Gualerzi
May 2, 2013·ACS Chemical Biology·Joanna TrylskaZofia Dąbrowska
Aug 21, 2021·Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry·Hans Renata
Jan 9, 2021·Journal of the American Chemical Society·Christian R ZwickHans Renata